AG
Ankurkumar Gopalbhai Bhalodiya
About Ankurkumar Gopalbhai Bhalodiya
Data last updated:
Ankurkumar Gopalbhai Bhalodiya is a Director at Zeon Biotech Private Limited (since 2018), Director at Auroma Life Science Private Limited (since 2017) and Director at Bombay Generics Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, BFSI and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹25.25 Cr; the largest is Zeon Biotech Private Limited at ₹24.10 Cr (FY 2024). Earlier, Ankurkumar Gopalbhai Bhalodiya was a Director at Aan Lifescience Private Limited (2017–2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 17 Apr 2018 | 2018 | ₹24.10 Cr (FY 2024) | Active | |
| Director | 28 Mar 2017 | 2003 | ₹1.01 Cr (FY 2024) | Active | |
| Director | 01 Feb 2021 | 1989 | ₹14.8 Lakh (FY 2024) | Active | |
| Director | 02 Jul 2025 | 2025 | Active | ||
| Designated Partner | 10 Jul 2017 | 2017 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Nov 2017 | 2017 | ₹31.79 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ankurkumar Gopalbhai Bhalodiya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dimpal Bhalodiya | 08726809 | Zeon Biotech Private Limited , Bombay Generics Private Limited and 1 more | Director |
| Krushnakant Bhalodia | 07858208 | Zeon Biotech Private Limited , Auroma Life Science Private Limited and 3 more | Director |
| Poojaben Bhalodiya | 08726874 | Zeon Biotech Private Limited , Bombay Generics Private Limited and 1 more | Director |
| Bakulkumar Jayantilal Padia | 00388763 | Bombay Generics Private Limited | Director |
| Bharatkumar Babulal Patel | 07480261 | Bombay Generics Private Limited | Director |
| Krunal Dilipkumar Sanghavi | 03645069 | Bombay Generics Private Limited | Director |
| Snehalbhai Jashwantbhai Shah | 06897940 | Bombay Generics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ankurkumar Gopalbhai Bhalodiya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ankurkumar Gopalbhai Bhalodiya
Ankurkumar Gopalbhai Bhalodiya currently holds 5 directorships: Zeon Biotech Private Limited (Director, since 17 Apr 2018, revenue ₹24.10 Cr (FY 2024)); Auroma Life Science Private Limited (Director, since 28 Mar 2017, revenue ₹1.01 Cr (FY 2024)); Bombay Generics Private Limited (Director, since 01 Feb 2021, revenue ₹14.8 Lakh (FY 2024)); Zeon Capital Limited (Director, since 02 Jul 2025); Aplus Engitech Llp (Designated Partner, since 10 Jul 2017).
Ankurkumar Gopalbhai Bhalodiya was first appointed on 28 Mar 2017 as Director at Auroma Life Science Private Limited. The most recent appointment on record is 02 Jul 2025 at Zeon Capital Limited.
The 3 current companies of Ankurkumar Gopalbhai Bhalodiya that report revenue have a combined latest revenue of ₹25.25 Cr: Zeon Biotech Private Limited ₹24.10 Cr (FY 2024); Auroma Life Science Private Limited ₹1.01 Cr (FY 2024); Bombay Generics Private Limited ₹14.8 Lakh (FY 2024).
Ankurkumar Gopalbhai Bhalodiya held 1 earlier board appointment: Aan Lifescience Private Limited (Director, 14 Nov 2017 to 25 May 2019).
The current boards of Ankurkumar Gopalbhai Bhalodiya's companies include Dimpal Bhalodiya (Zeon Biotech Private Limited), Krushnakant Bhalodia (Zeon Biotech Private Limited), Poojaben Bhalodiya (Zeon Biotech Private Limited), Bakulkumar Jayantilal Padia (Bombay Generics Private Limited), Bharatkumar Babulal Patel (Bombay Generics Private Limited), Krunal Dilipkumar Sanghavi (Bombay Generics Private Limited), among others.